Greylin Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $4.68M | Sell |
14,971
-889
| -6% | -$261K | 0.78% | 26 |
|
|
2024
Q1 | $4.51M | Sell |
15,860
-14,707
| -48% | -$4.3M | 0.72% | 27 |
|
|
2023
Q4 | $8.8M | Sell |
30,567
-4,034
| -12% | -$1.1M | 1.52% | 11 |
|
|
2023
Q3 | $9.3M | Sell |
34,601
-3,697
| -10% | -$923K | 1.67% | 10 |
|
|
2023
Q2 | $8.5M | Buy |
38,298
+286
| +0.8% | +$66.4K | 1.54% | 12 |
|
|
2023
Q1 | $9.19M | Sell |
38,012
-411
| -1% | -$101K | 1.68% | 12 |
|
|
2022
Q4 | $10.1M | Sell |
38,423
-285
| -0.7% | -$76.4K | 1.86% | 12 |
|
|
2022
Q3 | $8.72M | Sell |
38,708
-1,387
| -3% | -$336K | 1.81% | 14 |
|
|
2022
Q2 | $9.76M | Sell |
40,095
-432
| -1% | -$106K | 1.89% | 14 |
|
|
2022
Q1 | $9.8M | Buy |
40,527
+544
| +1% | +$125K | 1.68% | 14 |
|
|
2021
Q4 | $8.99M | Buy |
39,983
+17,892
| +81% | +$3.78M | 1.7% | 12 |
|
|
2021
Q3 | $4.7M | Buy |
22,091
+20,046
| +980% | +$4.61M | 0.96% | 23 |
|
|
2021
Q2 | $498K | Buy |
2,045
+141
| +7% | +$34.7K | 0.1% | 68 |
|
|
2021
Q1 | $474K | Buy |
1,904
+132
| +7% | +$31.5K | 0.1% | 72 |
|
|
2020
Q4 | $407K | Buy |
1,772
+10
| +0.6% | +$2.31K | 0.1% | 67 |
|
|
2020
Q3 | $448K | Sell |
1,762
-3,785
| -68% | -$938K | 0.12% | 59 |
|
|
2020
Q2 | $1.31M | Sell |
5,547
-1,735
| -24% | -$396K | 0.37% | 32 |
|
|
2020
Q1 | $1.48M | Sell |
7,282
-5,255
| -42% | -$1.15M | 0.46% | 31 |
|
|
2019
Q4 | $3.02M | Sell |
12,537
-3,320
| -21% | -$732K | 0.67% | 24 |
|
|
2019
Q3 | $3.07M | Sell |
15,857
-55
| -0.3% | -$10.6K | 0.73% | 23 |
|
|
2019
Q2 | $2.93M | Buy |
15,912
+3,180
| +25% | +$569K | 0.66% | 24 |
|
|
2019
Q1 | $2.42M | Sell |
12,732
-250
| -2% | -$47.7K | 0.54% | 33 |
|
|
2018
Q4 | $2.53M | Sell |
12,982
-2,775
| -18% | -$541K | 0.61% | 27 |
|
|
2018
Q3 | $3.27M | Buy |
15,757
+25
| +0.2% | +$4.93K | 0.7% | 24 |
|
|
2018
Q2 | $2.9M | Buy |
15,732
+1,292
| +9% | +$229K | 0.63% | 27 |
|
|
2018
Q1 | $2.46M | Buy |
14,440
+55
| +0.4% | +$10.1K | 0.53% | 30 |
|
|
2017
Q4 | $2.5M | Buy |
14,385
+328
| +2% | +$58K | 0.54% | 28 |
|
|
2017
Q3 | $2.62M | Buy |
14,057
+27
| +0.2% | +$4.78K | 0.6% | 23 |
|
|
2017
Q2 | $2.42M | Buy |
14,030
+11,555
| +467% | +$1.88M | 0.56% | 25 |
|
|
2017
Q1 | $406K | Buy |
2,475
+430
| +21% | +$71.4K | 0.09% | 58 |
|
|
2016
Q4 | $299K | Buy |
2,045
+697
| +52% | +$105K | 0.07% | 61 |
|
|
2016
Q3 | $225K | Buy |
+1,348
| New | +$228K | 0.06% | 71 |
|
|
2014
Q3 | – | Sell |
-5,168
| Closed | -$612K | – | 67 |
|
|
2014
Q2 | $612K | Sell |
5,168
-960
| -16% | -$111K | 0.15% | 43 |
|
|
2014
Q1 | $756K | Sell |
6,128
-100
| -2% | -$12.1K | 0.18% | 40 |
|
|
2013
Q4 | $710K | Buy |
+6,228
| New | +$708K | 0.18% | 43 |
|
Other funds holding AMGN
Greylin Investment Management's AMGN Position: Q2 2024 in Review
Greylin Investment Management reduced its Amgen (AMGN) stake by 5.6% in Q2 2024, selling an estimated $261K and leaving 14,971 shares worth $4.68M. The position accounts for 0.78% of the portfolio, ranked #26.
Greylin Investment Management first reported a position in AMGN in Q4 2013 and has held it in 35 quarters since. The position peaked at $10.1M in Q4 2022. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.
- Greylin Investment Management held 14,971 shares of Amgen worth $4.68M as of Q2 2024.
- Greylin Investment Management sold 889 Amgen shares in Q2 2024, an estimated $261K.
- Amgen made up 0.78% of Greylin Investment Management's portfolio in Q2 2024, its #26 holding.
- Greylin Investment Management first reported a position in Amgen in Q4 2013 and has held it in 35 quarters since.
- Greylin Investment Management's Amgen position peaked at $10.1M in Q4 2022.
- 2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.
Based on Greylin Investment Management's 13F filing for Q2 2024, filed 19 Jul 2024.